Evidence map›Paper›PMID 30226366›Full record

ArticleAnalytical chemistry2018

Screening Estrogen Receptor Modulators in a Paper-Based Breast Cancer Model.

Nathan A Whitman, Zhi-Wei Lin, Thomas J DiProspero, Julie C McIntosh, Matthew R Lockett

Open access · greenAbstract read
In one paragraph

Article in Analytical chemistry, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.9field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 21 citations in OpenAlex.

  1. Review
  2. A high-throughputActa pharmaceutica Sinica. B · 2023
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Nathan A WhitmanDepartment of Chemistry, Kenan and Caudill Laboratories , University of North Carolina at Chapel Hill , 125 South Road , Chapel Hill , North Carolina 27599-3290 , United States.
Zhi-Wei LinDepartment of Chemistry, Kenan and Caudill Laboratories , University of North Carolina at Chapel Hill , 125 South Road , Chapel Hill , North Carolina 27599-3290 , United States.
Thomas J DiProsperoDepartment of Chemistry, Kenan and Caudill Laboratories , University of North Carolina at Chapel Hill , 125 South Road , Chapel Hill , North Carolina 27599-3290 , United States.
Julie C McIntoshDepartment of Chemistry, Kenan and Caudill Laboratories , University of North Carolina at Chapel Hill , 125 South Road , Chapel Hill , North Carolina 27599-3290 , United States.
Matthew R LockettDepartment of Chemistry, Kenan and Caudill Laboratories , University of North Carolina at Chapel Hill , 125 South Road , Chapel Hill , North Carolina 27599-3290 , United States.ORCID 0000-0003-4851-7757
University of North Carolina at Chapel Hill · US

Funding

Re-Entry Supplement: Investigation of Oral Microbial Enzymes for the Detection and Treatment of Periodontal DiseaseUL1TR002489 · NCATS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI BUSE, JOHN BERNARD, SHAHEEN, NICHOLAS J · 2018 to 2022
$48.6M
North Carolina Translational & Clinical Sciences Institute (NC TraCS)UL1TR001111 · NCATS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI BUSE, JOHN BERNARD, CAREY, TIMOTHY S · 2013 to 2017
$43.9M
NCATS NIH HHS UL1 TR001111NCATS NIH HHS UL1 TR002489
6 · The paper itself

Abstract

The health risks associated with acute and prolonged exposure to estrogen receptor (ER) modulators has led to a concerted effort to identify and prioritize potential disruptors present in the environment. ER agonists and antagonists are identified with end-point assays, quantifying changes in cellular proliferation or gene transactivation in monolayers of estrogen receptor alpha expressing (ER+) cells upon exposure. While these monolayer cultures can be prepared, dosed, and analyzed in a highly parallelized manner, they are unable to predict the potencies of ER modulators in vivo accurately. Physiologically relevant model systems that better predict tissue- or organ-level responses are needed. To address this need, we describe here a screening platform capable of quantitatively assessing ER modulators in 96 chemically isolated 3D cultures. These cultures are supported in wax-patterned paper scaffolds whose design has improved performance and throughput over previously described paper-based setups. To highlight the potential of paper-based cultures for toxicity screens, we measured the potency of known ER modulators with a luciferase-based reporter assay. We also quantified the proliferation and invasion of two ER+ cell lines in the presence of estradiol. Despite the inability of the current setup to better predict in vivo potencies of ER modulators than monolayer cultures, the results demonstrate the potential of this platform to support increasingly complex and physiologically relevant tissue-like structures for environmental chemical risk assessment.

Indexed as

PaperAntineoplastic AgentsBreast NeoplasmsCell ProliferationDose-Response Relationship, DrugDrug Evaluation, PreclinicalDrug Screening Assays, AntitumorEnzyme-Linked Immunosorbent AssayEstrogen Receptor alphaEstrogen Receptor AntagonistsEstrogen Receptor ModulatorsEstrogensFemaleHumansMCF-7 CellsStructure-Activity RelationshipAntineoplastic AgentsESR1 protein, humanEstrogen Receptor alphaEstrogen Receptor AntagonistsEstrogen Receptor ModulatorsEstrogens

Identifiers

PMID30226366
PMCPMC6200649
OpenAlexW2890921561

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.